Key Published Findings
Knee Osteoarthritis
A 2023 randomized controlled trial published in Life compared HILT (High-Intensity Laser Therapy, i.e., Class IV) to LLLT (Class III) as adjuncts to standard rehabilitation exercises. The HILT group demonstrated 50% greater pain reduction, 20% greater improvement in knee function scores, and 6% greater improvement in active knee flexion compared to the LLLT group — with HILT's gains exceeding the minimal clinically important difference threshold.
A 2025 narrative review and meta-analysis in Osteoarthritis and Cartilage Open found that PBM significantly reduced knee pain (VAS reduction of 14.23 mm, 95% CI: 7.31–21.14) and reduced disability compared to placebo, with benefits persisting at follow-up visits.
Neck Pain
An early meta-analysis of 11 trials reported a mean VAS pain reduction of 19.86 mm for neck pain, with effects persisting at 22-week follow-up (mean VAS reduction 22.07 mm) — clinically meaningful and durable outcomes.
Adhesive Capsulitis (Frozen Shoulder)
A 2023 randomized clinical trial published in the Saudi Journal of Medicine & Medical Sciences found that HILT produced significantly better outcomes than LLLT after 3 weeks of treatment for both pain and disability in patients with frozen shoulder
Chronic Musculoskeletal Pain — Systematic Review
A 2021 systematic review in Physiotherapy Quarterly evaluated 7 RCTs on Class IV laser for musculoskeletal conditions (including patellofemoral dysfunction, epicondylitis, osteoarthritis, cervicalgia, and lumbar radiculopathy). All studies had low risk of bias (PEDro score > 7). Results confirmed: significant pain reduction at end of treatment and at follow-up evaluations (p < 0.005); significant reduction in disability (p < 0.005).
Chronic Pain — Broad Systematic Review
A 2026 systematic review in Frontiers in Integrative Neuroscience, covering RCTs published between 2015 and 2025, concluded that PBM demonstrates analgesic potential and a safe profile for managing chronic pain — particularly fibromyalgia and peripheral neuropathy — with low incidence of adverse events.
Multiple Health Outcomes — Umbrella Review
A comprehensive 2025 umbrella review of meta-analyses published in Systematic Reviews (PMC) assessed PBM across all health domains. PBM demonstrated significant effects for 12 distinct outcomes with moderate certainty of evidence for knee osteoarthritis disability, and improvements in pain across burning mouth syndrome, neck pain, tendinopathy, fibromyalgia, and temporomandibular disorders .
Plantar Fasciitis
A 2026 study in Lasers in Medical Science confirmed that Class IV laser therapy combined with plantar fascia stretching produced superior outcomes (greater pain reduction, improved pressure pain threshold, enhanced foot function) compared to other conservative treatments — with no adverse effects reported.
Athletic Performance and Muscle Recovery
A 2021 systematic review of 24 studies in Sports Health confirmed that photobiomodulation significantly improved lower-limb muscle strength and reduced post-exercise muscle damage markers (creatine kinase, IL-6) at 24-, 48-, and 96-hour follow-up intervals.
Postoperative Pain
A pilot study of 100 cardiac surgery patients (Karlekar et al., Annals of Cardiac Anaesthesia, 2015) found that Class IV laser therapy (5–7 J/cm²) significantly reduced postoperative pain scores compared to standard multimodal analgesia, with no adverse effects on wound healing — offering a compelling non-pharmacological adjunct for post-surgical recovery.
Where the Evidence Stands Today
The published literature consistently supports Class IV laser therapy as a safe, effective, and non-invasive modality for pain relief, inflammation reduction, and accelerated tissue healing. It surpasses lower-power laser therapy (LLLT/Class III) in head-to-head comparisons for several key conditions. The primary area requiring continued research is protocol standardization — optimal dosing, wavelength combinations, and session frequencies across specific populations — which ongoing multicenter trials are actively addressing.
